Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2005
03/24/2005WO2004105701A3 Compositions and methods for symptomatic relief
03/24/2005WO2004087860A3 Materials and methods for regulating process formation in cell culture
03/24/2005WO2004047746A3 Regulation of stearoyl-coa desaturase to treat obesity
03/24/2005WO2004033635A3 Retinal pigment epithelial cell cultures on amniotic membrane and transplantation
03/24/2005WO2003105875A8 Immunostimulator having antineoplastic action and method for producing said immunostimulator
03/24/2005US20050066379 Preparing somatic embryo by utilizing rabbit oocyte
03/24/2005US20050066375 Genetic engineered rodent comprising gene sequences coding antigenic recognition and/or cell activation of T cell polypeptide for use in treatment and prevention of infection, viral, nervous system and inflammatory diseases
03/24/2005US20050065107 Plasmids suitable for IL-2 expression
03/24/2005US20050064596 Buffer solution for electroporation and a method comprising the use of the same
03/24/2005US20050064591 Washing heart tissue in alcohol, water and glycosidase to remove carbohydrate moieties in preparation of engraftment in human; tissue repair and engineering; transplantation
03/24/2005US20050064588 Epidermal melanocyte culture formulations
03/24/2005US20050064587 Pancreatic small cells and uses thereof
03/24/2005US20050064586 Somatic cell derived embryonic stem cells and its differentiated cells
03/24/2005US20050064568 Tyrissamycin antibiotic
03/24/2005US20050064491 Transport protein for use as tool in identifying modulator for treatment of sleep, nervous suystem, anixety, eating, cardiovascular and pain disordere
03/24/2005US20050064440 Using single nucleotide polymorphism in contactin-2 (CNTN-2) and kinesin-7 (CENP-E) genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference
03/24/2005US20050064416 Methods for diagnosing and treating heart disease
03/24/2005US20050064041 Continuous exchange of a predetermined volume of a demineralizing acid solution; use in tissue repair of bone; faster, less damaging to the osteoinductive properties
03/24/2005US20050063993 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering
03/24/2005US20050063964 A natural enzymatic starter and water are added to a rye fine or coarse meal, heated fermentation to form maltose, further addition of meal and fermentation with a lactic acid bacteria, acidification; cosmetics
03/24/2005US20050063961 Hematopoietic stem cells and endothelial progenitor cells; express the cell surface antigen CD31; delivering transgenes to the eye for cell-based gene therapy; treating ocular diseases such as retinopathy
03/24/2005US20050063959 By transfection with an an osteo-/chondro-inducible transcription factor gene such as Cbfa1, Dlx-5, Bapx1, Msx2, Scleraxis, or Sox9, and allowing the cells to differentiate and proliferate on a scaffold; implants
03/24/2005US20050063958 Ex vivo gene therapy for HIV; formulation of CD34+ hematopoietic cells transduced with a viral construct which expresses an anti-HIV agent such as a ribozyme
03/24/2005US20050063957 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system
03/24/2005US20050063954 Recombinant reovirus for treating a Ras-mediated proliferative disorder such as tumors
03/24/2005DE102004028302A1 Stimulierung der Synthese und der Aktivität einer Isoform der Lysyloxidase-ähnlichen LOXL zum Stimulieren der Bildung von elastischen Fasern Stimulation of the synthesis and the activity of one isoform of the lysyl oxidase-like LOXL for stimulating the formation of elastic fibers
03/24/2005CA2539380A1 Method for producing insulin from a natural source and insulin
03/24/2005CA2538413A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
03/24/2005CA2538231A1 A method for treating or inhibiting the effects of injuries or diseases that result in neuronal degeneration
03/24/2005CA2537482A1 Use of adipose tissue cells for initiating the formation of a functional vascular network
03/24/2005CA2536655A1 Immortalisation of mammalian cells and therapeutic applications of said cells
03/23/2005EP1516932A1 Poxvirus with targeted infection specificity
03/23/2005EP1516922A1 Apparatus for use in the regeneration of structured human tissue
03/23/2005EP1516882A1 Composition containing a marine-derived inorganic substance and chitin/chitosan, and method of producing the composition
03/23/2005EP1516618A1 Coenzyme Q10 as antiapoptotic agent
03/23/2005EP1516597A1 Drug eluting stent
03/23/2005EP1516057A2 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity
03/23/2005EP1516052A1 Immunomodulation using altered dendritic cells
03/23/2005EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer
03/23/2005EP1515748A2 Anti-estrogen and immune modulator combinations for treating breast cancer
03/23/2005EP1515737A2 An ayurvedic nutritional preparation
03/23/2005EP1515735A1 Botulinum toxins for treating priapism
03/23/2005EP1515734A1 Honey-based skin care preparation
03/23/2005EP1515733A2 Method for preparing a solid-fibrin web
03/23/2005EP1421182A4 Methods of inducing differentiation of stem cells
03/23/2005EP1343542B1 Carrier with solid fibrinogen and solid thrombin
03/23/2005EP1297119B9 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current
03/23/2005EP1228373B1 Diagnosis and therapy of cancer using sgp28-related molecules
03/23/2005EP1181382B1 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
03/23/2005EP1114166B1 Method for down-regulating osteoprotegerin ligand activity
03/23/2005EP0772456B1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement
03/23/2005CN1599793A Chondrocyte precursors derived from human embryonic stem cells
03/23/2005CN1599792A Nutrient medium for maintaining neural cells in injured nervous system
03/23/2005CN1599626A Use of micro-organisms for a directed delivery of substances to specific parts of the gut
03/23/2005CN1599617A Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
03/23/2005CN1597935A Process for extracting stem cell of umbilical cord living cell placental cyonin
03/23/2005CN1596912A Multifunctional compound medicine for treating burn, chemical substance ambustion and its skin disease
03/23/2005CN1596911A Production method of enzymolysis forest frog oil and softcapsule
03/23/2005CN1596910A Human platelet substitute and its preparation method
03/23/2005CN1596733A Animal brain extract and food component composition for enhancing psycological stress adaptation
03/23/2005CN1194086C Preparing method method of neural stem cell preparation,
03/23/2005CN1194083C Preparing method of deer blood wine
03/23/2005CN1193783C External used medicine against piles
03/23/2005CN1193778C Medicine liquid for treating burns and scalds
03/23/2005CN1193775C Medicine for treating atrophic arthritis, ankylosing sponylitis
03/23/2005CN1193773C Capsule agent of chanhua mycelia and preparing method thereof
03/23/2005CN1193772C Capsule for dredging channels and removing blood stasis and its making method
03/23/2005CN1193771C Exterior-applied Chinese medicine for preventing and rteating ejaculation praecox and its preparing process
03/23/2005CN1193770C Hydrolytic extrating method for medicinal component of pilose anler and product
03/22/2005US6870043 For broad use in therapy and prevention including antisense agents and vaccines
03/22/2005US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use
03/22/2005US6869795 Antisense compositions and cancer-treatment methods
03/22/2005US6869621 Diet composition comprising raw foods and dietary fibers
03/22/2005US6869602 Method for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections with bovine red blood cells
03/22/2005US6869510 Methods and apparatus for processing the surface of a microelectronic workpiece
03/22/2005CA2482116A1 Apparatus for use in the regeneration of structured human tissue
03/22/2005CA2142638C Antibiotic wap-8294a, method for preparing the same and antibacterial composition
03/17/2005WO2005024016A1 Mutant hsv vector useful in treating human glioma
03/17/2005WO2005024004A1 Method of differentiating mesenchymal stem cell into liver cell and artificial human liver cell
03/17/2005WO2005023996A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS
03/17/2005WO2005023324A1 Meniscal superfacial zone cells for articular cartilage repair
03/17/2005WO2005023277A1 A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
03/17/2005WO2005023276A1 Pharmaceutical active agent against breast cancer
03/17/2005WO2005023275A1 Pharmaceutical active ingredient against hepatitis
03/17/2005WO2004099395A3 A method for the generation of neural progenitor cells
03/17/2005WO2004098622A3 Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic-pituitary-adrenal axis over-activity
03/17/2005WO2004082669A3 Antiflatulents in combibation with histamine h1-receptor antagonist for treating gastrointestinal disoders
03/17/2005WO2003011898A3 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
03/17/2005US20050060779 Lectin-derived progenitor cell preservation factors and methods of use
03/17/2005US20050059953 Apparatus for demineralizing osteoinductive bone
03/17/2005US20050059864 Periosteal distraction
03/17/2005US20050059601 by administering an exendin peptide analog of given amino acid sequence; treating Type II diabetes, eating disorders, and insulin-resistance syndrome
03/17/2005US20050059594 Administering macrophage derived factor; oncomodulin
03/17/2005US20050059152 Culturing mesenchymal primordial cell tissues isolated from cord blood into biological scaffolds for use in repairing damaged tissue; regenerative medicies; tissue repair and replacement; tissue engineering
03/17/2005US20050059151 Compositions and methods for priming monocytic dendritic cells and t cells for th-1response
03/17/2005US20050059147 Human mesenchymal progenitor cell
03/17/2005US20050059145 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells
03/17/2005US20050059144 MHC class II antigen-presenting systems and methods for activating CD4+ T cells
03/17/2005US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
03/17/2005US20050059051 Expression vector comprising nucleotide sequences coding transmembrane protein for use as tool in stimulating lymphocyte response and treatment and prevention of inflammatory and autoimmune diseases